IsleNova provides comprehensive, end-to-end islet cell isolation services in support of total pancreatectomy with islet autotransplantation (TPIAT) — serving as a trusted independent partner to physicians and clinical institutions.
We deliver specialized, high-quality islet cell processing with a strong commitment to reliability, regulatory compliance, patient safety, and clinical outcomes. Our highly specialized team integrates clinical procedural experience with innovative cellular technologies to maximize islet cell yield, quality, and viability from both normal and diseased pancreatic tissue. This expertise enables optimal restoration of pancreatic endocrine function and improved quality of life for patients with chronic pancreatitis and other conditions who have limited therapeutic options.
Our workflow is designed to integrate seamlessly with your surgical program — minimizing disruption while maximizing islet yield and transplant viability.
We are building our physician network ahead of Phase I launch. Register your interest now and be first to know when services go live.